P573: NOVEL PROGNOSTIC MODEL FOR RELAPSE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

P573: NOVEL PROGNOSTIC MODEL FOR RELAPSE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

Bibliographic Details
Main Authors:	Qi Wen, Shuang Fan, Hao-Yang Hong, Xiao-Hui Zhang, Lanping Xu, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Meng-Zhu Shen, Xiao-Jun Huang, Shen-Da Hong, Xiao-Dong Mo
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000969196.90043.d6

Similar Items

A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation
by: Meng-Zhu Shen, et al.
Published: (2022-03-01)

Machine learning algorithm as a prognostic tool for Epstein-Barr virus reactivation after haploidentical hematopoietic stem cell transplantation
by: Shuang Fan, et al.
Published: (2023-03-01)

A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation
by: Meng-Zhu Shen, et al.
Published: (2022-05-01)

Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation
by: Pier Edoardo Rovatti, et al.
Published: (2020-02-01)

Efficacy and Safety of Unmanipulated Haploidentical Related Donor Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia
by: Li-Ping Dou, et al.
Published: (2018-01-01)

The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia
by: Ya-Zhen Qin, et al.
Published: (2017-02-01)

Preemptive Interferon-α Therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Results of Two Registry Studies
by: Meng-Zhu Shen, et al.
Published: (2022-01-01)

Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective
by: Ying-Jun Chang, et al.
Published: (2021-10-01)

Successful hematopoietic stem cell transplantation with haploidentical donors and non-irradiation conditioning in patients with Fanconi anemia
by: Jing-Zhi Wang, et al.
Published: (2021-10-01)

Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
by: Shuang Fan, et al.
Published: (2022-01-01)

Preemptive interferon-α therapy could prevent relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: A real-world analysis
by: Shuang Fan, et al.
Published: (2023-02-01)

Wilms’ tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation
by: Dao-Xing Deng, et al.
Published: (2021-03-01)

Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft--host disease after haploidentical allogeneic hematopoietic stem cell transplantation
by: Meng-Zhu Shen, et al.
Published: (2022-01-01)

Comparison of clinical features of nephrotic syndrome after haploidentical and matched donor hematopoietic stem cell transplantation
by: Wei Sun, et al.
Published: (2024-02-01)

Haploidentical versus Double-Cord Blood Stem Cells as a Second Transplantation for Relapsed Acute Myeloid Leukemia
by: Jong-Hyuk Lee, et al.
Published: (2023-01-01)

Unmanipulated haploidentical hematopoietic stem cell transplantation for pediatric de novo acute megakaryoblastic leukemia without Down syndrome in China: A single-center study
by: Junbin Huang, et al.
Published: (2023-02-01)

PB2418: CLINICAL FEATURES AND PROGNOSIS OF ADENOVIRUS INFECTION AFTER HAPLOIDENTICAL DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Wei Sun, et al.
Published: (2023-08-01)

Association of iKIR-mismatch model and donor aKIRs with better outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia
by: Yu Zhang, et al.
Published: (2023-01-01)

Successful haploidentical stem cell transplantation for therapy‐related acute myeloid leukemia after autologous transplantation of Hodgkin lymphoma
by: Chien‐Yu Ker, et al.
Published: (2022-08-01)

Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation
by: Xun-Hong Cao, et al.
Published: (2024-03-01)

Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long‐term clinical outcomes and health‐related quality of life assessment
by: Chen‐hua Yan, et al.
Published: (2022-12-01)

Acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation presenting as pericardial effusion
by: Yuyan Shen, et al.
Published: (2023-10-01)

Current status of haploidentical stem cell transplantation for leukemia
by: Huang Xiao-jun
Published: (2008-12-01)

Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
by: Jing Liu, et al.
Published: (2018-01-01)

Molecular monitoring of minimal residual disease in two patients with <it>MLL</it>-rearranged acute myeloid leukemia and haploidentical transplantation after relapse
by: Burmeister Thomas, et al.
Published: (2012-04-01)

Effectiveness of T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation for Refractory/Relapsed B Cell Acute Lymphoblastic Leukemia in Children and Adolescents
by: Hideki Sano, et al.
Published: (2021-10-01)

Brain toxoplasmosis after HLA haploidentical transplantation for acute myeloid leukemia
by: Takafumi Tsushima, et al.
Published: (2022-08-01)

Efficacy of Decitabine and Venetoclax as Salvage and Bridge Therapy to Haploidentical Hematopoietic Stem Cell Transplantation in a Multiresistant Acute Myeloid Leukemia Patient
by: Bianca Serio, et al.
Published: (2022-06-01)

Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantation
by: Hejin Jia, et al.
Published: (2019-06-01)

Review of Haploidentical Hematopoietic Cell Transplantation
by: Mehreen A. Khan, et al.
Published: (2018-12-01)

The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
by: Enrico Maffini, et al.
Published: (2022-11-01)

Effects of Peripheral Blood Stem Cell Transplantation from Haploidentical Versus Matched Sibling Donors on High-risk and Refractory/Relapsed Acute Myeloid Leukemia
by: MIAO Wenyan, et al.
Published: (2023-10-01)

Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation
by: Ya-Zhen Qin, et al.
Published: (2016-05-01)

Comparisons of Long-Term Survival and Safety of Haploidentical Hematopoietic Stem Cell Transplantation After CAR-T Cell Therapy or Chemotherapy in Pediatric Patients With First Relapse of B-Cell Acute Lymphoblastic Leukemia Based on MRD-Guided Treatment
by: Guanhua Hu, et al.
Published: (2022-06-01)

Successful Haploidentical Hematopoietic Stem Cell Transplantation with Azacitidine and Venetoclax Maintenance Therapy for Acute Myeloid Leukemia with NUP98-RARG Gene Fusion
by: Jiaojiao Yuan, et al.
Published: (2023-03-01)

Haploidentical hematopoietic stem cell transplantation may improve long-term survival for children with high-risk T-cell acute lymphoblastic leukemia in first complete remission
by: Yongzhan Zhang, et al.
Published: (2022-04-01)

Prophylactic NAC promoted hematopoietic reconstitution by improving endothelial cells after haploidentical HSCT: a phase 3, open-label randomized trial
by: Yu Wang, et al.
Published: (2022-04-01)

Second allogeneic hematopoietic stem cell transplantation in treatment of relapsed acute myeloid leukemia: clinical report of 5 cases
by: LIN Shijia, et al.
Published: (2019-12-01)

Adoptive transfer of CMV-specific TCR-T cells for the treatment of CMV infection after haploidentical hematopoietic stem cell transplantation
by: Yu Wang, et al.
Published: (2024-01-01)

Improved outcome of children with relapsed/refractory acute myeloid leukemia by addition of cladribine to re‐induction chemotherapy
by: Min Ruan, et al.
Published: (2021-02-01)